# Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

> **NCT00800709** · PHASE4 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 26 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT00800709
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2010-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800709, "Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00800709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*